Literature DB >> 35506245

Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study.

Joshua W Bliss1, Jessica A Lavery2, Whitney P Underwood2, Su S Chun2, Gina A Fickera2, Catherine P Lee2, Stacie Corcoran2, Molly A Maloy2, Fernanda C Polubriaginof2, Daniel W Kelly2, Jessica M Scott1,2, Paul C Boutros3,4,5,6, Chaya S Moskowitz1,2, Lee W Jones1,2.   

Abstract

BACKGROUND: Modifiable lifestyle-related factors heighten the risk and severity of coronavirus disease 2019 (COVID-19) in patients with cancer. Whether exercise lowers susceptibility or severity is not known.
METHODS: We identified 944 cancer patients from Memorial Sloan Kettering Cancer Center (mean age: 64; 85% female; 78% White) completing an exercise survey before receiving a confirmed positive or negative SARS-CoV-2 test. Exercise was defined as reporting moderate-intensity ≥5 days per week, ≥30 minutes/session or strenuous-intensity ≥3 days per week, ≥20 minutes/session. Multivariable logistic regression was used to determine the relationship between exercise and COVID-19 susceptibility and severity (i.e., composite of hospital admission or death events) with adjustment for clinical-epidemiologic covariates.
RESULTS: Twenty-four percent (230/944) of the overall cohort were diagnosed with COVID-19 and 35% (333/944) were exercisers. During a median follow-up of 10 months, 26% (156/611) of nonexercising patients were diagnosed with COVID-19 compared with 22% (74/333) of exercising patients. The adjusted OR for risk of COVID-19 was 0.65 [95% confidence interval (CI), 0.44-0.96, P = 0.03] for exercisers compared with nonexercisers. A total of 20% (47/230) of COVID-19 positive patients were hospitalized or died. No difference in the risk of severe COVID-19 as a function of exercise status was observed (P > 0.9).
CONCLUSIONS: Exercise may reduce the risk of COVID-19 infection in patients with a history of cancer, but not its severity. IMPACT: This study provides the first data showing that exercise might lower the risk of COVID-19 in cancer patients, but further research is required. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 35506245      PMCID: PMC9135110          DOI: 10.1158/1055-9965.EPI-21-1186

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  44 in total

1.  Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial.

Authors:  Lee W Jones; Kerry S Courneya; Adrian S Fairey; John R Mackey
Journal:  Ann Behav Med       Date:  2004-10

2.  Covid-19 and Immunity in Aging Populations - A New Research Agenda.

Authors:  Wayne C Koff; Michelle A Williams
Journal:  N Engl J Med       Date:  2020-04-17       Impact factor: 91.245

3.  Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy.

Authors:  Lee W Jones; Diane R Fels; Miranda West; Jason D Allen; Gloria Broadwater; William T Barry; Lee G Wilke; Elisabeth Masko; Pamela S Douglas; Rajesh C Dash; Thomas J Povsic; Jeffrey Peppercorn; P Kelly Marcom; Kimberly L Blackwell; Gretchen Kimmick; Timothy G Turkington; Mark W Dewhirst
Journal:  Cancer Prev Res (Phila)       Date:  2013-07-10

4.  Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.

Authors:  Mengyuan Dai; Dianbo Liu; Miao Liu; Fuxiang Zhou; Guiling Li; Zhen Chen; Zhian Zhang; Hua You; Meng Wu; Qichao Zheng; Yong Xiong; Huihua Xiong; Chun Wang; Changchun Chen; Fei Xiong; Yan Zhang; Yaqin Peng; Siping Ge; Bo Zhen; Tingting Yu; Ling Wang; Hua Wang; Yu Liu; Yeshan Chen; Junhua Mei; Xiaojia Gao; Zhuyan Li; Lijuan Gan; Can He; Zhen Li; Yuying Shi; Yuwen Qi; Jing Yang; Daniel G Tenen; Li Chai; Lorelei A Mucci; Mauricio Santillana; Hongbing Cai
Journal:  Cancer Discov       Date:  2020-04-28       Impact factor: 39.397

5.  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

Authors:  Nicole M Kuderer; Toni K Choueiri; Dimpy P Shah; Yu Shyr; Samuel M Rubinstein; Donna R Rivera; Sanjay Shete; Chih-Yuan Hsu; Aakash Desai; Gilberto de Lima Lopes; Petros Grivas; Corrie A Painter; Solange Peters; Michael A Thompson; Ziad Bakouny; Gerald Batist; Tanios Bekaii-Saab; Mehmet A Bilen; Nathaniel Bouganim; Mateo Bover Larroya; Daniel Castellano; Salvatore A Del Prete; Deborah B Doroshow; Pamela C Egan; Arielle Elkrief; Dimitrios Farmakiotis; Daniel Flora; Matthew D Galsky; Michael J Glover; Elizabeth A Griffiths; Anthony P Gulati; Shilpa Gupta; Navid Hafez; Thorvardur R Halfdanarson; Jessica E Hawley; Emily Hsu; Anup Kasi; Ali R Khaki; Christopher A Lemmon; Colleen Lewis; Barbara Logan; Tyler Masters; Rana R McKay; Ruben A Mesa; Alicia K Morgans; Mary F Mulcahy; Orestis A Panagiotou; Prakash Peddi; Nathan A Pennell; Kerry Reynolds; Lane R Rosen; Rachel Rosovsky; Mary Salazar; Andrew Schmidt; Sumit A Shah; Justin A Shaya; John Steinharter; Keith E Stockerl-Goldstein; Suki Subbiah; Donald C Vinh; Firas H Wehbe; Lisa B Weissmann; Julie Tsu-Yu Wu; Elizabeth Wulff-Burchfield; Zhuoer Xie; Albert Yeh; Peter P Yu; Alice Y Zhou; Leyre Zubiri; Sanjay Mishra; Gary H Lyman; Brian I Rini; Jeremy L Warner
Journal:  Lancet       Date:  2020-05-28       Impact factor: 79.321

6.  Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK.

Authors:  Mark Hamer; Mika Kivimäki; Catharine R Gale; G David Batty
Journal:  Brain Behav Immun       Date:  2020-05-23       Impact factor: 7.217

7.  COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.

Authors:  Lennard Yw Lee; Jean-Baptiste Cazier; Vasileios Angelis; Roland Arnold; Vartika Bisht; Naomi A Campton; Julia Chackathayil; Vinton Wt Cheng; Helen M Curley; Matthew W Fittall; Luke Freeman-Mills; Spyridon Gennatas; Anshita Goel; Simon Hartley; Daniel J Hughes; David Kerr; Alvin Jx Lee; Rebecca J Lee; Sophie E McGrath; Christopher P Middleton; Nirupa Murugaesu; Thomas Newsom-Davis; Alicia Fc Okines; Anna C Olsson-Brown; Claire Palles; Yi Pan; Ruth Pettengell; Thomas Powles; Emily A Protheroe; Karin Purshouse; Archana Sharma-Oates; Shivan Sivakumar; Ashley J Smith; Thomas Starkey; Chris D Turnbull; Csilla Várnai; Nadia Yousaf; Rachel Kerr; Gary Middleton
Journal:  Lancet       Date:  2020-05-28       Impact factor: 79.321

8.  Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.

Authors:  Ana Campos Codo; Gustavo Gastão Davanzo; Lauar de Brito Monteiro; Gabriela Fabiano de Souza; Stéfanie Primon Muraro; João Victor Virgilio-da-Silva; Juliana Silveira Prodonoff; Victor Corasolla Carregari; Carlos Alberto Oliveira de Biagi Junior; Fernanda Crunfli; Jeffersson Leandro Jimenez Restrepo; Pedro Henrique Vendramini; Guilherme Reis-de-Oliveira; Karina Bispo Dos Santos; Daniel A Toledo-Teixeira; Pierina Lorencini Parise; Matheus Cavalheiro Martini; Rafael Elias Marques; Helison R Carmo; Alexandre Borin; Laís Durço Coimbra; Vinícius O Boldrini; Natalia S Brunetti; Andre S Vieira; Eli Mansour; Raisa G Ulaf; Ana F Bernardes; Thyago A Nunes; Luciana C Ribeiro; Andre C Palma; Marcus V Agrela; Maria Luiza Moretti; Andrei C Sposito; Fabrício Bíscaro Pereira; Licio Augusto Velloso; Marco Aurélio Ramirez Vinolo; André Damasio; José Luiz Proença-Módena; Robson Francisco Carvalho; Marcelo A Mori; Daniel Martins-de-Souza; Helder I Nakaya; Alessandro S Farias; Pedro M Moraes-Vieira
Journal:  Cell Metab       Date:  2020-07-17       Impact factor: 27.287

9.  COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.

Authors:  Marina Chiara Garassino; Jennifer G Whisenant; Li-Ching Huang; Annalisa Trama; Valter Torri; Francesco Agustoni; Javier Baena; Giuseppe Banna; Rossana Berardi; Anna Cecilia Bettini; Emilio Bria; Matteo Brighenti; Jacques Cadranel; Alessandro De Toma; Claudio Chini; Alessio Cortellini; Enriqueta Felip; Giovanna Finocchiaro; Pilar Garrido; Carlo Genova; Raffaele Giusti; Vanesa Gregorc; Francesco Grossi; Federica Grosso; Salvatore Intagliata; Nicla La Verde; Stephen V Liu; Julien Mazieres; Edoardo Mercadante; Olivier Michielin; Gabriele Minuti; Denis Moro-Sibilot; Giulia Pasello; Antonio Passaro; Vieri Scotti; Piergiorgio Solli; Elisa Stroppa; Marcello Tiseo; Giuseppe Viscardi; Luca Voltolini; Yi-Long Wu; Silvia Zai; Vera Pancaldi; Anne-Marie Dingemans; Jan Van Meerbeeck; Fabrice Barlesi; Heather Wakelee; Solange Peters; Leora Horn
Journal:  Lancet Oncol       Date:  2020-06-12       Impact factor: 41.316

10.  COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.

Authors:  Lennard Y W Lee; Jean-Baptiste Cazier; Thomas Starkey; Sarah E W Briggs; Roland Arnold; Vartika Bisht; Stephen Booth; Naomi A Campton; Vinton W T Cheng; Graham Collins; Helen M Curley; Philip Earwaker; Matthew W Fittall; Spyridon Gennatas; Anshita Goel; Simon Hartley; Daniel J Hughes; David Kerr; Alvin J X Lee; Rebecca J Lee; Siow Ming Lee; Hayley Mckenzie; Chris P Middleton; Nirupa Murugaesu; Tom Newsom-Davis; Anna C Olsson-Brown; Claire Palles; Thomas Powles; Emily A Protheroe; Karin Purshouse; Archana Sharma-Oates; Shivan Sivakumar; Ashley J Smith; Oliver Topping; Chris D Turnbull; Csilla Várnai; Adam D M Briggs; Gary Middleton; Rachel Kerr
Journal:  Lancet Oncol       Date:  2020-08-24       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.